Triple

T17421982
Position Surface form Disambiguated ID Type / Status
Subject Goppenstein E423638 entity
Predicate locatedOnRiver P165 FINISHED
Object Lonza NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Lonza | Statement: [Goppenstein, locatedOnRiver, Lonza]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Lonza
Context triple: [Goppenstein, locatedOnRiver, Lonza]
  • A. Lonza
    Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
  • B. Boehringer Ingelheim
    Boehringer Ingelheim is a major German research-driven pharmaceutical company known for developing prescription medicines, animal health products, and biopharmaceuticals worldwide.
  • C. Novartis
    Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
  • D. Ciba-Geigy
    Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
  • E. Roche
    Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Lonza
Target entity description: Lonza is a river in the Swiss canton of Valais that flows through the Lötschental valley before joining the Rhône.
  • A. Lonza
    Lonza is a global Swiss-based life sciences company specializing in pharmaceutical, biotech, and nutrition products and services, particularly in contract development and manufacturing.
  • B. Boehringer Ingelheim
    Boehringer Ingelheim is a major German research-driven pharmaceutical company known for developing prescription medicines, animal health products, and biopharmaceuticals worldwide.
  • C. Novartis
    Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
  • D. Ciba-Geigy
    Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
  • E. Roche
    Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d889d7d27c819088486ce3f0627fa1 completed April 10, 2026, 5:25 a.m.
NER Named-entity recognition batch_69e44237f2cc819083ca0e7e00d828fb completed April 19, 2026, 2:47 a.m.
Created at: April 10, 2026, 5:46 a.m.